Covid-19: See latest data on suppliers and inventory

Tria Bioscience

1616 Eastlake Ave E, Suite 260, Seattle, WA 98102, United States
TRIA Bioscience Corporation specifies their major offering areas as: Conjugate Vaccines Development, Research & Development, Therapeutics, Monoclonal Antibodies, and Development of Therapeutic Antibodies.
DUNS #:
831016907
CAGE Code:
5KRA4
Type:
Manufacturer
Employees:
1-10
Annual Revenue:
Less than $1M
Year Founded:
2009
Country of Origin:
United States
Sectors Served:
US Federal, Private Sector
Company Security Level:
Unknown
Credit Card Usage:
No

Specialties and Expertise:

Research & Development, Novel Therapeutic Antibodies, Monoclonal Antibodies, Immunogenicity, Synthetic Universal Flu Vaccine, Vaccine Development, Cross-Protective Monoclonal Antibodies, H5N1 Prote...

Contact/Location Info3

Size and minority status

Size
Small business
Ownership
African American
Alaska Native
Asian-Indian
Asian-Pacific
Hispanic
Minority-Unspecified
Native American
Native Hawaiian
Tribal
Unspecified
Veteran
Woman
Government Set-Aside Programs
AbilityOne
HUBZone
SBA 8(a)
SDVOSB
Small Disadvantaged Business (SDB)
Woman Owned Small Business (WOSB)

Commodity Codes1

PRODUCTS AND SERVICES2

Conjugate Vaccines Development
TRIA Bioscience is focusing on the development of conjugate vaccines. Conjugate vaccines replace traditional protein carriers with smaller synthetic peptides and are very effective in preventing pneumonia and meningitis.
Synthetic Universal Flu Vaccine
1 past experience
TRIA Biosciences is developing a multi-valent universal Flu vaccine using a proprietary synthetic peptide to achieve robust immune responses to traditionally weak antigens.

Past experience7

SBIR
Advanced Design of a Nicotine Vaccine for S...
Tobacco smoke is the primary cause of lung cancer, cardiovascular disease, and premature death, with nearly 5 million people dying e...
SBIR
Cross-Protective Monoclonal Antibodies for ...
Influenza is a highly contagious respiratory disease that causes substantial mortality worldwide. There is great international conce...
SBIR
Pandemic H5N1 vaccine containing recombinan...
H5N1 is a highly pathogenic avian influenza virus that can cause severe disease and death in humans. H5N1 is spreading rapidly in bi...
SBIR
Protective vaccine for H5N1 Flu using H5 pr...
H5N1 is a highly pathogenic avian influenza virus that can cause severe disease and death in humans. H5N1 is spreading rapidly in bi...

Known Locations Served1

  • United States 1 location
My Notes
Contact
My Notes